Table 5. Top 11 enriched KEGG pathways between oil-fumigated and control samples.
No. | Pathway ID | Pathway | Number of sequences | Q value a |
---|---|---|---|---|
1 | ko03050 | Proteasome | 30 (1.22%) | 1.99e-03 |
2 | ko04976 | Bile secretion | 50 (2.04%) | 1.48e-02 |
3 | ko00980 | Metabolism of xenobiotics by cytochrome P450 | 30 (1.22%) | 1.48e-02 |
4 | ko04145 | Phagosome | 90 (3.66%) | 2.29e-02 |
5 | ko04520 | Adherens junction | 58 (2.36%) | 2.29e-02 |
6 | ko04810 | Regulation of actin cytoskeleton | 110 (4.48%) | 2.30e-02 |
7 | ko05204 | Chemical carcinogenesis | 30 (1.22%) | 2.34e-02 |
8 | ko00982 | Drug metabolism- cytochrome P450 | 30 (1.22%) | 2.66e-02 |
9 | ko00040 | Pentose and glucuronate interconversions | 28 (1.14%) | 3.79e-02 |
10 | ko04141 | Protein processing in endoplasmic reticulum | 73 (2.97%) | 4.06e-02 |
11 | ko04640 | Hematopoietic cell lineage | 34 (1.38%) | 4.34e-02 |
The pathway functional enrichment was analyzed using the hypergeometric test with FDR adjusted p values ≤ 0.01.
a Significant enriched KEGG pathways were separated with a multiple correction method of Q values < 0.05.